Literature DB >> 16564450

Tibial nonunion.

Anthony P Mechrefe1, Eugene Y Koh, Peter G Trafton, Christopher W DiGiovanni.   

Abstract

Nonunions of the tibia represent challenging orthopedic problems, which require the surgeon to analyze numerous factors and choose an appropriate treatment. Tibial nonunion treatment requires establishing its existence and cause. The treatment algorithm necessitates consideration of a wide variety of factors: the location of the nonunion, the presence or absence of infection, and any angular or rotational deformity. Given advances in implant design and biologic agents, a wide variety of management options exist for the treatment of tibial nonunions. This article reviews surgical treatments for tibial nonunions.

Entities:  

Mesh:

Year:  2006        PMID: 16564450     DOI: 10.1016/j.fcl.2005.12.003

Source DB:  PubMed          Journal:  Foot Ankle Clin        ISSN: 1083-7515            Impact factor:   1.653


  4 in total

1.  Long-term functional outcome and quality of life after successful surgical treatment of tibial nonunions.

Authors:  Florian Wichlas; Serafim Tsitsilonis; Alexander C Disch; Norbert P Haas; Christian Hartmann; Frank Graef; Philipp Schwabe
Journal:  Int Orthop       Date:  2014-12-20       Impact factor: 3.075

2.  Proximal ulna non-union: treatment concept and postoperative outcome.

Authors:  Tim Jakobi; Yves Gramlich; Matthias Sauter; Sebastian Fischer; Reinhard Hoffmann; Alexander Klug
Journal:  Int Orthop       Date:  2022-09-14       Impact factor: 3.479

3.  A treatment for large defects of the tibia caused by infected nonunion: Ilizarov method with bone segment extension.

Authors:  K Xu; X Fu; Y-M Li; C-G Wang; Z-J Li
Journal:  Ir J Med Sci       Date:  2013-10-29       Impact factor: 1.568

4.  Autogenous iliac crest bone grafting for tibial nonunions revisited: does approach matter?

Authors:  Sanjit R Konda; Connor P Littlefield; Kurtis D Carlock; Abhishek Ganta; Philipp Leucht; Kenneth A Egol
Journal:  Arch Orthop Trauma Surg       Date:  2021-01-08       Impact factor: 3.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.